Cite
HARVARD Citation
Kawamata, A. et al. (2022). Monitoring of Programmed Cell Death Ligand-1 Blockade Using FDG PET/CT for Microsatellite Instability-High Metastatic Breast Cancer. Clinical nuclear medicine. pp. e252-e253. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kawamata, A. et al. (2022). Monitoring of Programmed Cell Death Ligand-1 Blockade Using FDG PET/CT for Microsatellite Instability-High Metastatic Breast Cancer. Clinical nuclear medicine. pp. e252-e253. [Online].